Hypopyon, a term derived from the Greek words “hypo” meaning “under” and “pyon” meaning “pus,” is a critical ocular condition characterized by the accumulation of white blood cells or pus in the anterior chamber of the eye. This condition serves as a significant indicator of various underlying issues, ranging from infections to inflammatory disorders. Timely diagnosis and proper treatment are pivotal to prevent vision loss or severe complications. This detailed guide aims to provide an in-depth understanding of hypopyon, covering its causes, symptoms, diagnosis, and treatment options.

1. Infections: 
   • Bacterial: Hypopyon commonly arises from bacterial infections, often associated with corneal ulcers, trauma, or contact lens wear. Bacterial keratitis, caused by organisms such as Staphylococcus aureus, Pseudomonas aeruginosa, or Streptococcus pneumoniae, can lead to hypopyon formation. 
   • Fungal: Fungal keratitis, particularly in agricultural regions or tropical climates, is another significant cause of hypopyon. Fusarium and Aspergillus species are among the common fungal pathogens implicated in fungal keratitis-related hypopyon. 
   • Viral: Although less common, viral infections such as herpes simplex virus (HSV) or varicella-zoster virus (VZV) can lead to herpetic keratitis-associated hypopyon. These viral pathogens may cause recurrent episodes of anterior uveitis with characteristic keratic precipitates and hypopyon formation.
2. Inflammatory Disorders:
   • Uveitis: Anterior uveitis, characterized by inflammation of the iris and ciliary body, is a common cause of hypopyon. Non-infectious uveitis, including idiopathic anterior uveitis or HLA-B27-associated anterior uveitis, can manifest with hypopyon as part of the inflammatory cascade. 
   • Scleritis: Severe scleritis, an autoimmune inflammatory disorder affecting the sclera, may lead to hypopyon formation secondary to scleral vessel inflammation and leakage. Necrotizing scleritis with inflammation extending into the anterior chamber can present with hypopyon and significant ocular morbidity. 
   • Behçet’s Disease: Behçet’s disease, a systemic vasculitis of unknown etiology, is characterized by recurrent episodes of uveitis with hypopyon, along with oral and genital ulcers, skin lesions, and systemic inflammation. Hypopyon in Behçet’s disease often reflects the severity of ocular involvement and requires aggressive immunomodulatory therapy.
3. Autoimmune Diseases:
   • Rheumatoid Arthritis: Systemic autoimmune diseases like rheumatoid arthritis may manifest with ocular involvement, including scleritis, keratitis, or uveitis with hypopyon. Rheumatoid arthritis-associated hypopyon typically occurs in the setting of severe anterior uveitis and requires close collaboration between rheumatologists and ophthalmologists for optimal management. 
   • Lupus: Systemic lupus erythematosus (SLE) can present with various ocular manifestations, including lupus retinopathy, optic neuropathy, or uveitis with hypopyon. Lupus-associated hypopyon may signify active systemic disease and warrants comprehensive evaluation and treatment by a multidisciplinary team.
4. Post-Surgical Complications: 
   • Endophthalmitis: Postoperative endophthalmitis, characterized by severe intraocular inflammation and hypopyon formation, is a dreaded complication of ocular surgeries such as cataract extraction, vitrectomy, or corneal transplantation. Prompt diagnosis and aggressive management with intravitreal antibiotics and vitrectomy are essential to salvage vision and prevent permanent visual loss.

1. Eye Pain: 
   • Quality: Patients with hypopyon often describe a sharp, stabbing pain or a deep, throbbing ache within the eye. The pain may intensify with eye movements or external pressure on the globe. 
   • Location: The location of the pain may vary depending on the underlying cause of hypopyon, with corneal involvement typically resulting in superficial pain and uveitis-associated hypopyon causing deep-seated discomfort.
2. Redness and Swelling: 
   • Conjunctival Injection: The affected eye appears red and inflamed due to conjunctival injection, reflecting underlying vascular dilation and inflammation. The conjunctiva may exhibit diffuse or sectoral hyperemia, depending on the extent of ocular involvement.
   • Periocular Edema: Periorbital edema, or swelling around the eye, may accompany hypopyon due to the inflammatory response and tissue fluid accumulation. Eyelid edema and periorbital erythema may be prominent in severe cases of hypopyon.
3. Blurred Vision:
   • Visual Acuity Changes: Hypopyon can cause a decrease in visual acuity or blurred vision, particularly if the pus accumulates near the visual axis and interferes with light transmission. Patients may report difficulty reading, driving, or performing activities requiring clear vision. 
   • Discomfort with Eye Movements: Blurred vision may worsen with eye movements or changes in gaze direction, indicating mechanical obstruction or intraocular inflammation affecting visual function.
4. Sensitivity to Light: 
   • Photophobia:  Photophobia, or sensitivity to light, is a hallmark symptom of hypopyon, often prompting patients to seek shade or wear sunglasses even in indoor environments. Photophobia may result from corneal involvement, intraocular inflammation, or ciliary body spasm. 
   • Painful Glare:  Exposure to bright light sources may exacerbate ocular discomfort and pain, leading to avoidance of well-lit environments. Painful glare and squinting may be observed in patients with severe photophobia.
5. Decreased Eye Movement: 
   • Limitation of Motility: In severe cases of hypopyon, patients may experience restricted eye movement due to pain, inflammation, or mechanical obstruction caused by pus accumulation within the anterior chamber. Limited ocular motility may be noted on ocular examination, particularly in cases of associated scleritis or orbital cellulitis.

1. Ocular Examination: 
   • Visual Acuity Testing: Visual acuity assessment with Snellen chart or other standardized methods is essential to establish baseline visual function and monitor changes over time. It helps quantify the extent of visual impairment caused by hypopyon and guides treatment decisions. 
   • Slit-Lamp Biomicroscopy: Slit-lamp examination allows detailed visualization of the anterior segment structures, including the cornea, anterior chamber, iris, and lens. Hypopyon appears as a layered accumulation of white blood cells or pus in the anterior chamber, typically settling inferiorly due to gravity. The depth, extent, and characteristics of hypopyon are carefully evaluated to assess the severity of the condition and plan appropriate management. 
   • Dilated Fundus Examination: Dilated fundoscopic evaluation enables visualization of the posterior segment structures, including the retina, optic nerve, and vitreous. Concurrent retinal pathology or optic nerve involvement may coexist with anterior segment findings in cases of severe hypopyon. Fundus examination helps rule out associated posterior segment complications and ensures comprehensive assessment of ocular health.
2. Laboratory Investigations:
   • Microbiological Culture: Corneal scraping, conjunctival swab, or aqueous humor analysis may be performed to obtain samples for microbiological culture and sensitivity testing. Identifying the causative microorganism helps guide targeted antibiotic therapy and ensures appropriate management of infectious hypopyon. Microbiological culture also aids in detecting antibiotic resistance patterns, facilitating personalized treatment strategies.
   • Inflammatory Markers: Measurement of inflammatory markers in the aqueous humor or serum, such as interleukin-6 (IL-6) or tumor necrosis factor-alpha (TNF-alpha), may provide valuable insights into the underlying inflammatory process. Elevated levels of inflammatory cytokines correlate with disease activity and severity, guiding the selection of anti-inflammatory or immunomodulatory therapy in non-infectious hypopyon cases. Monitoring inflammatory markers during treatment helps assess treatment response and adjust therapeutic interventions accordingly.

1. Antibiotic Therapy: 
   • Topical Antibiotics: Broad-spectrum antibiotic eye drops or ointments, such as fluoroquinolones, aminoglycosides, or fortified antibiotics, are the mainstay of treatment for infectious hypopyon. Topical antibiotics penetrate the cornea and anterior chamber, effectively targeting bacterial pathogens and preventing further spread of infection. The choice of antibiotic agent depends on the suspected causative organism, local antimicrobial resistance patterns, and clinical response to therapy. 
   • Systemic Antibiotics: In cases of severe or refractory infectious hypopyon, systemic antibiotic therapy may be warranted to achieve adequate intraocular drug concentrations and eradicate systemic or hematogenous sources of infection. Oral antibiotics with good ocular penetration, such as fluoroquinolones or cephalosporins, are prescribed in conjunction with topical therapy to optimize treatment outcomes and minimize the risk of systemic complications.
2. Anti-inflammatory Medications: 
   • Corticosteroids: Topical corticosteroid eye drops, such as prednisolone acetate or dexamethasone, are commonly used to suppress intraocular inflammation and reduce hypopyon-related symptoms. Corticosteroids inhibit the production of inflammatory mediators, stabilize cell membranes, and attenuate immune responses within the eye. Treatment with corticosteroids is initiated after controlling the infectious component of hypopyon to prevent exacerbation of microbial proliferation or corneal thinning. Steroid therapy is tapered gradually based on clinical response and resolution of inflammation. 
   • Nonsteroidal Anti-inflammatory Drugs (NSAIDs): Adjunctive therapy with topical NSAIDs may be considered to provide additional anti-inflammatory effects and alleviate ocular discomfort in patients with hypopyon. NSAIDs inhibit cyclooxygenase enzymes, thereby reducing prostaglandin synthesis and suppressing inflammatory pathways. Combination therapy with corticosteroids and NSAIDs may offer synergistic benefits in controlling intraocular inflammation and improving visual outcomes.
3. Immunomodulatory Therapy:
   • Immunosuppressive Agents: In cases of non-infectious hypopyon associated with autoimmune or inflammatory disorders, immunomodulatory therapy aims to modulate immune responses and prevent disease recurrence. Immunosuppressive drugs such as methotrexate, cyclosporine, or azathioprine may be used as steroid-sparing agents to achieve long-term disease control. Biologic agents targeting specific cytokines or immune pathways, such as tumor necrosis factor-alpha (TNF-alpha) inhibitors or interleukin-6 (IL-6) antagonists, offer targeted therapy for refractory cases of hypopyon.
4. Surgical Intervention:
   • Anterior Chamber Washout: Surgical drainage of hypopyon may be indicated in cases of significant pus accumulation or corneal decompensation. Anterior chamber washout with balanced salt solution or antibiotic irrigants helps evacuate purulent material, reduce intraocular pressure, and clear visual axis obstruction. Surgical intervention is performed under sterile conditions to minimize the risk of intraocular contamination and optimize treatment outcomes. 
   • Therapeutic Keratoplasty: In cases of corneal involvement or perforation secondary to infectious or inflammatory hypopyon, therapeutic keratoplasty may be considered to restore corneal integrity and visual function. Lamellar or penetrating keratoplasty techniques are employed to remove necrotic tissue, graft healthy donor corneal tissue, and promote corneal wound healing. Close postoperative monitoring is essential to detect graft rejection, infection recurrence, or other complications requiring prompt intervention.

Hypopyon is a sight-threatening ocular condition characterized by the accumulation of pus or white blood cells in the anterior chamber of the eye. Prompt diagnosis and appropriate management are crucial to prevent vision loss, ocular complications, and systemic sequelae. A multidisciplinary approach involving ophthalmologists, infectious disease specialists, rheumatologists, and other healthcare providers is often required to address the diverse etiology and complex nature of hypopyon. By implementing a combination of antimicrobial therapy, anti-inflammatory agents, immunomodulatory drugs, and surgical interventions, clinicians can effectively control intraocular inflammation, promote ocular healing, and preserve visual function in patients with hypopyon. Long-term follow-up and monitoring are essential to monitor treatment response, detect disease recurrence, and optimize visual outcomes for improved patient quality of life.

World Eye Care Foundation’s eyecare.live brings you the latest information from various industry sources and experts in eye health and vision care. Please consult with your eye care provider for more general information and specific eye conditions. We do not provide any medical advice, suggestions or recommendations in any health conditions.